M. Strimfors

发表

Evaluation of exposure properties after injection of nanosuspensions and microsuspenions into the intraperitoneal space in rats

A. Lundqvist, K. Sigfridsson, M. Strimfors, 2013, Drug development and industrial pharmacy.

Particle size reduction and pharmacokinetic evaluation of a poorly soluble acid and a poorly soluble base during early development

A. Lundqvist, K. Sigfridsson, M. Strimfors, 2011, Drug development and industrial pharmacy.

Pharmacokinetics of BX211 after oral administration of nano- and microsuspensions to rats during early development

A. Lundqvist, P. Svanberg, K. Sigfridsson, 2009 .

A candidate drug administered subcutaneously to rodents as drug particles showing hepatic recirculation which influenced the sustained release process.

T. Arvidsson, K. Sigfridsson, Guangnong Zhang, 2020, International journal of pharmaceutics.

An obesity model and corona multiomics analysis reveal high-density lipoprotein effects on lipid nanoparticle function

A. Sabirsh, A. Salvati, J. Ulander, 2021 .

Discovery of AZD8165 – a clinical candidate from a novel series of neutral thrombin inhibitors

U. Bredberg, J. Bergman, S. Pehrsson, 2016 .

Nano- and microcrystals of griseofulvin subcutaneously administered to rats resulted in improved bioavailability and sustained release

Hanna Rydberg, Hanna A. Rydberg, K. Sigfridsson, 2019, Drug development and industrial pharmacy.

Particle size reduction for improvement of oral absorption of the poorly soluble drug UG558 in rats during early development

A. Lundqvist, K. Sigfridsson, Kalle Sigfridsson, 2009, Drug development and industrial pharmacy.

Co-administration of a nanosuspension of a poorly soluble basic compound and a solution of a proton pump inhibitor—the importance of gastrointestinal pH and solubility for the in vivo exposure

A. Lundqvist, K. Sigfridsson, M. Strimfors, 2011, Drug development and industrial pharmacy.

Mass Spectrometry Imaging proves differential absorption profiles of well-characterised permeability markers along the crypt-villus axis

P. Andrén, R. Goodwin, A. Nilsson, 2017, Scientific Reports.

Multiomics analysis of naturally efficacious lipid nanoparticle coronas reveals high-density lipoprotein is necessary for their function

A. Sabirsh, A. Salvati, J. Ulander, 2023, Nature communications.

Subcutaneous administration of nano- and microsuspensions of poorly soluble compounds to rats

A. Lundqvist, K. Sigfridsson, M. Strimfors, 2014, Drug development and industrial pharmacy.

Mass Spectrometry Imaging proves differential absorption profiles of well-characterised permeability markers along the crypt-villus axis

P. Andrén, R. Goodwin, A. Nilsson, 2017, Scientific Reports.